Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cetuximab with Gemcitabine in Advanced NSCLC
NCT00330746Phase 2Completed
- Sponsor
- National Cancer Institute
- Start
- Nov 2005
- Primary completion
- Jan 2008
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of KL-140 in non-small cell lung cancer (NSCLC), sponsored by National Cancer Institute. Started Nov 2005; status: completed.
02
Drugs
KL-140
03
Conditions
non-small cell lung cancer (NSCLC)
Beyond the preview
Go deeper on NCT00330746.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00330746.